What Is Tirzepatide? Dual GIP/GLP-1 Agonist Research Guide
Tirzepatide is a synthetic dual agonist that activates both the GIP and GLP-1 receptors. It is one of the most requested compounds in metabolic research procurement in South Africa. This guide explains what dual agonism means, how the molecule is constructed, and how research vials are handled.
Dual incretin agonism
The incretin system involves two gut hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Both influence insulin secretion in a glucose-dependent manner.
Single-agonist compounds act on GLP-1 alone. Tirzepatide is built on a GIP backbone with modifications that give it activity at both receptors, which is the basis of the comparative literature examining whether dual activation produces effects distinct from GLP-1 activation alone.
Structure and stability
Tirzepatide is a 39-amino-acid synthetic peptide carrying a C20 fatty diacid moiety. That lipid chain drives albumin binding, which is what gives the molecule its extended studied half-life of roughly five days.
The molecule is supplied lyophilised. Like other fatty-acylated peptides it is sensitive to agitation, so mixing technique matters more than with simple short peptides.
Reconstitution and storage
Use bacteriostatic water, added slowly against the vial wall. Do not shake — foaming indicates denaturation. Rotate the vial gently until fully dissolved; the solution should be clear and colourless.
Store sealed vials refrigerated or frozen and keep reconstituted solution at 2-8 °C. Our peptide calculator converts mg/mL to insulin-syringe units so preparation volumes can be planned before reconstitution.
Frequently asked questions
- How does Tirzepatide differ from a GLP-1 only agonist?
- Tirzepatide activates both the GIP and GLP-1 receptors, while single agonists act on GLP-1 alone. The comparative research literature examines whether that dual activation produces measurably different metabolic outcomes.
- Why does Tirzepatide have such a long half-life?
- It carries a C20 fatty diacid chain that binds serum albumin, slowing clearance. Published figures put the half-life at roughly five days.
- Can Tirzepatide be shaken when mixing?
- No. Shaking causes foaming and denaturation in fatty-acylated peptides. Add diluent down the vial wall and rotate gently until the solution is clear.
Browse the full Weight Loss & Metabolic Peptides range.
All information on this page is provided for laboratory and educational reference only. Peptides Lab SA (PTY) Ltd supplies compounds strictly for in-vitro research use. Nothing here is medical advice, a dosing recommendation, or a claim of human safety or efficacy.